| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/22/2004 | EP1460132A1 Antibodies with specific immunoreactivity to thyroid carcinoma cells |
| 09/22/2004 | EP1459756A1 REMOVAL PROMOTERS AND INHIBITOR FOR APOPTOSIS CELLS i IN VIVO /i |
| 09/22/2004 | EP1459635A1 Transglutaminase cross-linked soy protein composition, fish and meat products and analogues thereof |
| 09/22/2004 | EP1458885A2 The use of histamine h4 receptor antagonist for the treatment of inflammatory response |
| 09/22/2004 | EP1458871A2 Soluble recombinant protein production |
| 09/22/2004 | EP1458866A2 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 09/22/2004 | EP1458865A2 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 09/22/2004 | EP1458857A1 Hxhv virus, nucleic material, peptide material and uses |
| 09/22/2004 | EP1458845A2 Process and apparatus for performing a gas-sparged reaction |
| 09/22/2004 | EP1458758A2 Adiponectin fragments and conjugates |
| 09/22/2004 | EP1458756A1 Chemokine mutants acting as chemokine antagonists |
| 09/22/2004 | EP1458755A2 Novel g-protein coupled receptors and dna sequences thereof |
| 09/22/2004 | EP1458752A2 Polypeptides of pseudomonas aeruginosa |
| 09/22/2004 | EP1458411A2 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 09/22/2004 | EP1458403A2 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/22/2004 | EP1458247A2 Malleable protein matrix and uses thereof |
| 09/22/2004 | EP1458240A2 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 09/22/2004 | EP1409713A4 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES |
| 09/22/2004 | EP1350104A4 Presenilin enhancers |
| 09/22/2004 | EP1280819A4 Methods for the purification and aqueous fiber spinning of spider silks and other structural proteins |
| 09/22/2004 | EP1218396B1 Antibodies specific for fullerenes |
| 09/22/2004 | EP1009756B1 RECOMBINANT IgA |
| 09/22/2004 | EP1003871B1 Trichoderma reesei swollenin protein and encoding dna sequence |
| 09/22/2004 | EP0990044B1 A method for in vitro molecular evolution of protein function |
| 09/22/2004 | EP0970225B1 Improved metallo-endopeptidases |
| 09/22/2004 | EP0915970B1 Type c lectins |
| 09/22/2004 | EP0742822B1 Folding proteins |
| 09/22/2004 | EP0726914B1 Cell surface protein expressed on human cortical thymocyte and their use |
| 09/22/2004 | EP0636179B1 Oil-body proteins as carriers of high-value peptides in plants |
| 09/22/2004 | EP0587805B2 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1 |
| 09/22/2004 | CN1531653A Method for identification of proteins from intracellular bacteria |
| 09/22/2004 | CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene |
| 09/22/2004 | CN1531592A Process for preparation of neutrophil inhibitory factor |
| 09/22/2004 | CN1531590A Aspergillus ocharceus 11 alpha hydroxylase and oxidoreductase |
| 09/22/2004 | CN1531554A Humanized antibodies derived from DD-3B6-22, specific for D-dimer fragment of fibrin |
| 09/22/2004 | CN1531551A Production of insulinotropic secretion peptide GLP-1(7-36) and GLP-1 analog |
| 09/22/2004 | CN1531550A Heterocarpine, human GHRH-binding protein |
| 09/22/2004 | CN1530446A Method for separating and purifying ice nucleus active protein from ice nucleus active bacteria |
| 09/22/2004 | CN1530440A Monocolone antibody, encoding gene, its uses and hybrid nodule cell line for cecreting same |
| 09/22/2004 | CN1530373A Yeast extracted liquid for cell-free protein synthesis, preparation thereof, and cell-free protein synthesis therewith |
| 09/22/2004 | CN1167795C Novel peptide, novel DNA and novel antibody |
| 09/22/2004 | CN1167793C Polypeptides encoded by human lipase-like gene, compositions and methods |
| 09/22/2004 | CN1167712C Interleukin 11 analog |
| 09/21/2004 | US6794500 RNA-binding protein |
| 09/21/2004 | US6794496 Immunoassay for LSD and 2-oxo-3-hydroxy-LSD |
| 09/21/2004 | US6794363 Isolated amyloid inhibitor protein (APIP) and compositions thereof |
| 09/21/2004 | US6794361 Conotoxin polypeptide inhibits neuronal amine transporters; incontinence, cardiovascular disorders |
| 09/21/2004 | US6794187 Mass1 gene, a target for anticonvulsant drug development |
| 09/21/2004 | US6794181 Such as nisin; comprises incubation mixture containing a proteolytic enzyme; solid phase synthesis |
| 09/21/2004 | US6794180 Morphological mutants of filamentous fungi |
| 09/21/2004 | US6794171 D-pantolactone hydrolase and gene encoding the same |
| 09/21/2004 | US6794170 Nucleic acid fragment and vector comprising a halogenase, and a process for halogenating chemical compounds |
| 09/21/2004 | US6794162 Phage-dependent super-production of biologically active protein and peptides |
| 09/21/2004 | US6794149 GABA B receptors |
| 09/21/2004 | US6794145 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 09/21/2004 | US6794132 Human antibodies |
| 09/21/2004 | US6793925 Pseudomycin natural products |
| 09/21/2004 | US6793924 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated t cells and thereby inhibits t cell activation of b cells |
| 09/21/2004 | US6793920 Antithrombotic agent and anti-von willebrand factor monoclonal antibody |
| 09/21/2004 | CA2194032C Fused dna sequence, fused protein expressed from said fused dna sequence and method for expressing said fused protein |
| 09/20/2004 | CA2461400A1 Transglutaminase soy fish and meat products and analogs thereof |
| 09/16/2004 | WO2004078970A1 Branched neutral amino acid transporters acting as single molecule |
| 09/16/2004 | WO2004078965A1 Process for producing foreign protein in escherichia coli |
| 09/16/2004 | WO2004078964A1 Method of producing hybridoma and utilization thereof |
| 09/16/2004 | WO2004078953A1 Translocating enzyme used as a selection marker |
| 09/16/2004 | WO2004078936A2 Methods for preventing gluconoylation of proteins |
| 09/16/2004 | WO2004078933A2 Intracellular delivery of small molecules proteins and nucleic acids |
| 09/16/2004 | WO2004078928A2 T cell regulation |
| 09/16/2004 | WO2004078777A2 Dipeptidyl-peptidase protected proteins |
| 09/16/2004 | WO2004078140A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
| 09/16/2004 | WO2004078123A2 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use |
| 09/16/2004 | WO2004072225A3 Transgenic fungi expressing bcl-2 and methods of using bcl-2 or portions thereof for improving biomass production, survival, longevity, stress resistance and pathogenicity of fungi |
| 09/16/2004 | WO2004050846A8 Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines |
| 09/16/2004 | WO2004050679A3 Mutant glycoproteins |
| 09/16/2004 | WO2004048409A3 Mutants of the tumor necrosis factor alpha with deletion of n-terminal amino acids |
| 09/16/2004 | WO2004047762A3 Methods for treating cancer using porimin as a target |
| 09/16/2004 | WO2004034979A3 Monoclonal antibodies specific for cariogenic bacteria |
| 09/16/2004 | WO2003106658A3 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter |
| 09/16/2004 | WO2003099848A3 Method for universal enzymatic production of bioactive peptides |
| 09/16/2004 | WO2003089603A3 Cytokine receptor |
| 09/16/2004 | WO2003083041A8 Cripto-specific antibodies |
| 09/16/2004 | WO2003074657A3 Cold shock inducible expression and production of heterologous polypeptides |
| 09/16/2004 | WO2003052048A3 Nucleic acid-associated proteins |
| 09/16/2004 | WO2003045318A3 Manipulation of cytokine levels using cd83 gene products |
| 09/16/2004 | WO2003040307A3 Heteromultimeric tnf ligand family members |
| 09/16/2004 | WO2002062948A3 25828, a novel human aminopeptidase and uses therefor |
| 09/16/2004 | US20040181827 Plant Gntl sequences and the use thereof for the production of plants having reduced or lacking N-acetyl glucosaminyl transferase I (GnTI) activity |
| 09/16/2004 | US20040181047 33 human secreted proteins |
| 09/16/2004 | US20040181042 Antibody recognizing GM1 ganglioside-bound amyloid beta-protein and DNA encoding the antibody |
| 09/16/2004 | US20040181036 Mutant forms of cholera holotoxin as an adjuvant |
| 09/16/2004 | US20040181034 Multimeric Apo A-I agonist compounds |
| 09/16/2004 | US20040180826 Novel receptor that causes cell death |
| 09/16/2004 | US20040180421 Purification process |
| 09/16/2004 | US20040180411 Altering metabolism in biological processes |
| 09/16/2004 | US20040180407 Novel G protein coupled receptor protein, DNA and its ligand |
| 09/16/2004 | US20040180401 Methods of determining precise HERG interactions and designing compounds based on said interactions |
| 09/16/2004 | US20040180396 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 09/16/2004 | US20040180356 Comprises nucleotide sequences coding membrane proteins for use in diagnosis, prevention and treatment of cell proliferative, metabolic and inflammatory disorders |
| 09/16/2004 | US20040180354 Comprises polypeptides which are displayable on antigen presenting cells of immune system for use in prevention and treatment of infection and vaccine development; immunotherapy |
| 09/16/2004 | US20040180348 Method for surface display of proteins of genetic carriers |